FGF23 抗体
(Fibroblast Growth Factor 23 (FGF23))
This gene encodes a member of the fibroblast growth factor family of proteins, which possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. The product of this gene regulates phosphate homeostasis and transport in the kidney. The full-length, functional protein may be deactivated via cleavage into N-terminal and C-terminal chains. Mutation of this cleavage site causes autosomal dominant hypophosphatemic rickets (ADHR). Mutations in this gene are also associated with hyperphosphatemic familial tumoral calcinosis (HFTC). [provided by RefSeq, Feb 2013].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| FGF23 抗体 (AA 25-251) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 24-126) | 人 | 小鼠 Monoclonal |
|
|
|
| FGF23 抗体 (C-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 24-126) | 人 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 157-238) | 人 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 79-160) | 人 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 157-238) | 人 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 24-126) | 人 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 25-251) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 48-251) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 48-251) (Biotin) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 48-251) (HRP) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 25-251) (Biotin) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 25-251) (HRP) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 48-251) (Fluoro550) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 25-251) (Fluoro550) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 25-251) (APC) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 48-251) (APC) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 48-251) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF23 抗体 (AA 25-251) (FITC) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1-2#
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 抗原表位
- AA 24-126
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 24-126
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 157-238
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 79-160
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 157-238
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 24-126
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 48-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 48-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 48-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 48-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 48-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 48-251
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 25-251
Latest Publications for our FGF23 抗体
: "Management of intrathoracic phosphaturic mesenchymal tumor by nonintubated uniportal video-assisted thoracic surgery in a fragile patient." in: Cancer reports (Hoboken, N.J.), Vol. 5, Issue 5, pp. e1500, (2022) (PubMed).
: "Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction." in: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, Vol. 40, pp. 47-54, (2019) (PubMed).
: "MicroRNA-296 mediated corneal neovascularization in an animal model of corneal burns after alkali exposures." in: Experimental and therapeutic medicine, Vol. 15, Issue 1, pp. 139-144, (2018) (PubMed).
: "Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure." in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 31, Issue 5, pp. 767-72, (2016) (PubMed).
: "Inorganic polyphosphates stimulate FGF23 expression through the FGFR pathway." in: Biochemical and biophysical research communications, Vol. 428, Issue 2, pp. 298-302, (2012) (PubMed).
: "1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization ..." in: Experimental biology and medicine (Maywood, N.J.), Vol. 237, Issue 3, pp. 241-53, (2012) (PubMed).
: "Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 31, Issue 1, pp. 219-27, (2010) (PubMed).
: "Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production." in: The Journal of biological chemistry, Vol. 278, Issue 4, pp. 2206-11, (2003) (PubMed).
: "Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction." in: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, Vol. 40, pp. 47-54, (2019) (PubMed).
: "MicroRNA-296 mediated corneal neovascularization in an animal model of corneal burns after alkali exposures." in: Experimental and therapeutic medicine, Vol. 15, Issue 1, pp. 139-144, (2018) (PubMed).
: "Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure." in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 31, Issue 5, pp. 767-72, (2016) (PubMed).
: "Inorganic polyphosphates stimulate FGF23 expression through the FGFR pathway." in: Biochemical and biophysical research communications, Vol. 428, Issue 2, pp. 298-302, (2012) (PubMed).
: "1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization ..." in: Experimental biology and medicine (Maywood, N.J.), Vol. 237, Issue 3, pp. 241-53, (2012) (PubMed).
: "Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 31, Issue 1, pp. 219-27, (2010) (PubMed).
: "Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production." in: The Journal of biological chemistry, Vol. 278, Issue 4, pp. 2206-11, (2003) (PubMed).
Aliases for FGF23 抗体
fibroblast growth factor 23 (fgf23) 抗体fibroblast growth factor 23 (FGF23) 抗体
fibroblast growth factor 23 (Fgf23) 抗体
ADHR 抗体
FGF23 抗体
FGFN 抗体
HPDR2 抗体
HYPF 抗体
PHPTC 抗体
您还需要查找其他产品吗？
You are here:
